ENOV
Enovis Corp

89
Mkt Cap
$1.77B
Volume
598,743.00
52W High
$49.75
52W Low
$25.47
PE Ratio
-1.24
ENOV Fundamentals
Price
$29.99
Prev Close
$30.87
Open
$30.35
50D MA
$31.28
Beta
1.28
Avg. Volume
632,706.91
EPS (Annual)
-$14.93
P/B
0.85
Rev/Employee
$286,089.72
Loading...
Loading...
News
all
press releases
Boston Partners Decreases Stock Holdings in Enovis Corporation $ENOV
Boston Partners trimmed its position in shares of Enovis Corporation (NYSE:ENOV - Free Report) by 7.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
What is William Blair's Forecast for Enovis FY2025 Earnings?
Enovis Corporation (NYSE:ENOV - Free Report) - Equities research analysts at William Blair boosted their FY2025 earnings estimates for shares of Enovis in a research note issued on Thursday, November...
MarketBeat·5d ago
News Placeholder
Enovis (NYSE:ENOV) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS
Enovis (NYSE:ENOV - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.75 EPS for the quarter, beating analysts' consensus estimates of $0.67 by $0.08. The...
MarketBeat·6d ago
News Placeholder
Enovis (NYSE:ENOV) Price Target Raised to $42.00
Wells Fargo & Company lifted their price target on shares of Enovis from $41.00 to $42.00 and gave the stock an "overweight" rating in a research report on Friday...
MarketBeat·6d ago
News Placeholder
Envestnet Asset Management Inc. Raises Stake in Enovis Corporation $ENOV
Envestnet Asset Management Inc. lifted its position in shares of Enovis Corporation (NYSE:ENOV - Free Report) by 26.9% during the 2nd quarter, according to its most recent disclosure with the SEC...
MarketBeat·7d ago
News Placeholder
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
Enovis (ENOV) delivered earnings and revenue surprises of +11.94% and +2.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Wall Street Analysts Believe Enovis (ENOV) Could Rally 69.91%: Here's is How to Trade
The consensus price target hints at a 69.9% upside potential for Enovis (ENOV). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·2mo ago
News Placeholder
Does Enovis (ENOV) Have the Potential to Rally 77.33% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 77.3% in Enovis (ENOV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·3mo ago
News Placeholder
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
Enovis (ENOV) delivered earnings and revenue surprises of +6.76% and +1.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.
The orthopedic medical device company hit its 41st 52-week low. The stock looks unnecessarily beaten down, off 41% over the past 12 months and 62% from its all-time high in November 2021, making it a contrarian buy.
barchart.com·8mo ago

Latest ENOV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.